Response of chronic refractory psoriasis vulgaris with urticaria to combined secukinumab and omalizumab: A case report and review of the literature

被引：1

作者：

Abdelmaksoud, Ayman ^{[1
,2
,7
]}

Temiz, Selami Aykut ^{[3
]}

Daye, Munise ^{[3
]}

Yavuz, Sibel ^{[3
]}

Wollina, Uwe ^{[4
]}

Lotti, Torrllo ^{[5
,6
]}

Dursun, Recep ^{[3
]}

机构：

[1] Venerol & Leprol Hosp, Mansoura Dermatol, Mansoura, Egypt

[2] Univ Studies Guglielmo Marconi, Dept Dermatol, Rome, Italy

[3] Necmettin Erbakan Univ, Dept Dermatol, Meram Med Fac, Konya, Turkey

[4] Stadt Klinikum Dresden, Acad Teaching Hosp, Dept Dermatol & Allergol, Dresden, Germany

[5] Univ Rome G Marconi, Rome, Italy

[6] First Med State Moscow Univ IM Sechenev, Dept Dermatol & Communicable Dis, Moscow, Russia

[7] Venerol & Leprol Hosp, Mansoura Dermatol, 5-Amien Alsamanoudy St,Abdelsalam Aaref St, Mansoura, Egypt

来源：

JOURNAL OF COSMETIC DERMATOLOGY | 2023年 / 22卷 / 04期

关键词：

chronic spontaneous urticaria; omalizumab; psoriasis; secukinumab;

D O I：

10.1111/jocd.15551

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：1416 / 1418

页数：3

共 9 条

[1] Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels
Altrichter, S.
Hawro, T.
Haenel, K.
Czaja, K.
Luescher, B.
Maurer, M.
Church, M. K.
Baron, J. M.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (03) : 454 - 455
[2] Two Track Biologic Therapy for Concurrent Chronic Spontaneous Urticaria and Psoriasis Vulgaris in One Patient
Benkoa, M.
Stancica, B. Hrvatin
Lundera, T.
[J]. ACTAS DERMO-SIFILIOGRAFICAS, 2022, 113 (10): : 995 - 996
[3] Coesisting inflammatory skin diseases: Tildrakizumab to control psoriasis and omalizumab for urticaria
Diluvio, Laura
Pensa, Chiara
Piccolo, Arianna
Lanna, Caterina
Bianchi, Luca
Campione, Elena
[J]. DERMATOLOGIC THERAPY, 2022, 35 (04)
[4] Combining Omalizumab with Another Biotherapy
Fougerousse, Anne-Claire
Becherel, Pierre-Andre
Pallure, Valerie
Boye, Thierry
Reguiai, Ziad
Gabison, Germaine
Barthelemy, Hughes
Badaoui, Antoine
Mahe, Emmanuel
Bulai Livideanu, Cristina
[J]. ACTA DERMATO-VENEREOLOGICA, 2019, 99 (04) : 448 - 449
[5] KarstarliBakay OS., 2022, DERMATOL THER, V35
[6] Recurrent spontaneous clearance of psoriasis during exacerbations of concomitant chronic spontaneous urticaria
Magen, Eli
Chikovani, Tinatin
[J]. CLINICAL CASE REPORTS, 2020, 8 (08): : 1544 - 1546
[7] Omalizumab is not just an anti-immunoglobulin E
Ozaydin-Yavuz, Goknur
Yavuz, Ibrahim Halil
Inaloz, Huseyin Serhat
Boyvadoglu, Cagdas
[J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (06) : 2858 - 2861
[8] Serum tryptase levels in patients with psoriasis: a pilot study for a possible useful biomarker
Paolino, G.
Di Nicola, M. R.
Currado, M.
Brianti, P.
Mercuri, S. R.
[J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (01) : 178 - 179
[9] Urticaria Associated with Hyper-IgE in a Patient with Psoriasis Undergoing Treatment with Efalizumab
Saraceno, Rosita
Scotto, Gea
Chiricozzi, Andrea
Chimenti, Sergio
[J]. ACTA DERMATO-VENEREOLOGICA, 2009, 89 (04) : 412 - 413

← 1 →